Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now indicates enrollment is closed to new participants ('No longer looking for participants') and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). A minor formatting change updates the Intervention/Treatment heading (from 'Intervention / Treatment') and the revision label to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-18T02:13:08.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    The page shows an updated revision tag (v3.5.5) replacing the previous v3.5.4, signaling a small deployment update to the page metadata rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-03T19:19:56.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.5.3 to v3.5.4, indicating a recent update to the page's content or metadata. This reflects a backend or content refresh rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-05-20T16:50:45.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3, indicating a refreshed content version.
    Difference
    0.1%
    Check dated 2026-04-29T09:09:04.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Updated the page footer revision label from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-22T03:23:00.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The header now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-24T05:48:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.